EPOPROSTENOL for Heritable pulmonary arterial hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 17 adverse event reports in the FDA FAERS database where EPOPROSTENOL was used for Heritable pulmonary arterial hypertension.
Most Reported Side Effects for EPOPROSTENOL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 2,744 | 20.6% | 674 | 2,311 |
| Headache | 2,425 | 18.2% | 338 | 1,814 |
| Diarrhoea | 2,310 | 17.3% | 398 | 1,784 |
| Nausea | 2,016 | 15.1% | 345 | 1,606 |
| Pain in jaw | 1,928 | 14.5% | 302 | 1,484 |
| Death | 1,362 | 10.2% | 1,362 | 890 |
| Flushing | 1,256 | 9.4% | 143 | 930 |
| Fatigue | 1,133 | 8.5% | 191 | 875 |
| Hospitalisation | 1,078 | 8.1% | 234 | 1,074 |
| Vomiting | 1,068 | 8.0% | 200 | 891 |
| Pulmonary arterial hypertension | 1,055 | 7.9% | 475 | 864 |
| Malaise | 980 | 7.4% | 192 | 805 |
| Dyspnoea exertional | 938 | 7.0% | 179 | 822 |
| Fluid retention | 929 | 7.0% | 280 | 877 |
| Pain in extremity | 910 | 6.8% | 111 | 661 |
Other Indications for EPOPROSTENOL
Pulmonary arterial hypertension (8,508)
Pulmonary hypertension (2,486)
Product used for unknown indication (1,625)
Cor pulmonale chronic (239)
Portopulmonary hypertension (52)
Acute respiratory distress syndrome (42)
Covid-19 (26)
Right ventricular failure (25)
Pulmonary veno-occlusive disease (20)
Dyspnoea (19)
Other Drugs Used for Heritable pulmonary arterial hypertension
AMBRISENTAN (97)
TREPROSTINIL (48)
MACITENTAN (43)
RIOCIGUAT (27)
DILTIAZEM (21)
SELEXIPAG (19)
TADALAFIL (19)
SOTATERCEPT (7)
EPLERENONE (5)
SILDENAFIL (5)